Filing Flows › Angiodynamics (ANGO) › Free cash flow
Angiodynamics (ANGO) free cash flow by quarter
Angiodynamics' free cash flow was $17.0M in Q4 FY26 (fourth quarter fiscal 2026), +302% from Q2 FY26. Over the last 3 quarters it ranged from $4.2M (Q2 FY26) to $18.0M (Q4 FY25).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q4 FY26 | $17.0M | +302% | -6% |
| Q2 FY26 | $4.2M | -76% | — |
| Q4 FY25 | $18.0M | — | — |
Q4 FY26 at a glance
Angiodynamics, Q4 FY26: revenue $86.6M (+8% year over year), operating margin -11.8%, net loss $11.4M, operating cash flow $17.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Angiodynamics' free cash flow?
Angiodynamics' free cash flow was $17.0M in Q4 FY26 (fourth quarter fiscal 2026), +302% from Q2 FY26.
How has Angiodynamics' free cash flow changed?
Over the last 3 quarters it ranged from $4.2M (Q2 FY26) to $18.0M (Q4 FY25).